- Home
- HRTX vs WIA Comparison
HRTX vs WIA Comparison
Compare HRTX & WIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HRTX
- WIA
- Stock Information
- Founded
- HRTX 1983
- WIA 2003
- Country
- HRTX United States
- WIA United States
- Employees
- HRTX N/A
- WIA N/A
- Industry
- HRTX Biotechnology: Pharmaceutical Preparations
- WIA Trusts Except Educational Religious and Charitable
- Sector
- HRTX Health Care
- WIA Finance
- Exchange
- HRTX Nasdaq
- WIA Nasdaq
- Market Cap
- HRTX 180.5M
- WIA 191.5M
- IPO Year
- HRTX 1987
- WIA N/A
- Fundamental
- Price
- HRTX $1.06
- WIA $8.19
- Analyst Decision
- HRTX Strong Buy
- WIA
- Analyst Count
- HRTX 3
- WIA 0
- Target Price
- HRTX $5.67
- WIA N/A
- AVG Volume (30 Days)
- HRTX 2.1M
- WIA 39.2K
- Earning Date
- HRTX 11-12-2024
- WIA 01-01-0001
- Dividend Yield
- HRTX N/A
- WIA 12.29%
- EPS Growth
- HRTX N/A
- WIA N/A
- EPS
- HRTX N/A
- WIA N/A
- Revenue
- HRTX $137,737,000.00
- WIA N/A
- Revenue This Year
- HRTX $19.15
- WIA N/A
- Revenue Next Year
- HRTX $21.29
- WIA N/A
- P/E Ratio
- HRTX N/A
- WIA N/A
- Revenue Growth
- HRTX 12.13
- WIA N/A
- 52 Week Low
- HRTX $1.04
- WIA $7.56
- 52 Week High
- HRTX $3.93
- WIA $8.91
- Technical
- Relative Strength Index (RSI)
- HRTX 23.07
- WIA 38.38
- Support Level
- HRTX $1.04
- WIA $8.03
- Resistance Level
- HRTX $1.90
- WIA $8.39
- Average True Range (ATR)
- HRTX 0.13
- WIA 0.09
- MACD
- HRTX -0.05
- WIA -0.01
- Stochastic Oscillator
- HRTX 2.33
- WIA 44.44
About HRTX Heron Therapeutics Inc.
Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of APONVIE, SUSTOL, ZYNRELEF, and CINVANTI.
About WIA Western Asset Inflation-Linked Income Fund
Western Asset Inflation Linked Income Fund is a diversified, closed-end management investment company. The primary investment objective of the group is to provide current income while its secondary investment objective is capital appreciation.